✦ LIBER ✦

Histology as a treatment effect modifier in advanced non-small cell lung cancer: A systematic review of the evidence

✍ Scribed by LACHLAN STANDFIELD; ADÈLE R. WESTON; HELEN BARRACLOUGH; MAXIMILIANO VAN KOOTEN; NICK PAVLAKIS

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel and mitomycin as second-line t

✍ J. Feliu; G. Martín; J. Castro; A. Sundlov; A. Rodriguez-Jaráiz; E. Casado; M. L 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 209 KB

Bevacizumab in the treatment of non-smal

✍ Stinchcombe, T E; Socinski, M A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Cisplatin or carboplatin in the treatmen

✍ Marcello Tiseo; Andrea Ardizzoni 📂 Article 📅 2007 🏛 PAGEPress Publications 🌐 English ⚖ 99 KB

Endostar combined GC in the treatment of

✍ Changlin Zhao; Junbo Yuan; Ganlu Zhang; Fangjuan Hu; Xi Yu; Mingzhi Ren; Wenjun 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 315 KB

Targeted therapies in the treatment of a

✍ C. Gridelli; P. Maione; A. Rossi; C. Ferrara; G. Colantuoni; F. Del Gaizo; D. Ni 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 140 KB

Pemertrexed combined with cisplatin in t

✍ Changlin Zhao; Fangjuan Hu; Ganlu Zhang; Junbo Yuan; Wenjun Zhang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 313 KB